324 related articles for article (PubMed ID: 2340091)
1. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression.
Blum M; Grant DM; McBride W; Heim M; Meyer UA
DNA Cell Biol; 1990 Apr; 9(3):193-203. PubMed ID: 2340091
[TBL] [Abstract][Full Text] [Related]
2. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
3. N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits.
Blum M; Grant DM; Demierre A; Meyer UA
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9554-7. PubMed ID: 2594784
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts.
Boukouvala S; Sim E
Basic Clin Pharmacol Toxicol; 2005 May; 96(5):343-51. PubMed ID: 15853926
[TBL] [Abstract][Full Text] [Related]
5. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
Wagner CR; Bergstrom CP; Koning KR; Hanna PE
Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
Walraven JM; Doll MA; Hein DW
J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
[TBL] [Abstract][Full Text] [Related]
7. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
[TBL] [Abstract][Full Text] [Related]
8. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
[TBL] [Abstract][Full Text] [Related]
9. Two arylamine N-acetyltransferases from chicken pineal gland as identified by cDNA cloning.
Ohtomi M; Sasaki M; Deguchi T
Eur J Biochem; 1989 Nov; 185(2):253-61. PubMed ID: 2583181
[TBL] [Abstract][Full Text] [Related]
10. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
11. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
Smelt VA; Mardon HJ; Sim E
Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
[TBL] [Abstract][Full Text] [Related]
12. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
[TBL] [Abstract][Full Text] [Related]
13. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
Tsirka T; Boukouvala S; Agianian B; Fakis G
Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
[TBL] [Abstract][Full Text] [Related]
15. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
16. Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2.
Fakis G; Boukouvala S; Buckle V; Payton M; Denning C; Sim E
Cytogenet Cell Genet; 2000; 90(1-2):134-8. PubMed ID: 11060463
[TBL] [Abstract][Full Text] [Related]
17. Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis.
Fakis G; Boukouvala S; Kawamura A; Kennedy S
Pharmacogenet Genomics; 2007 Mar; 17(3):181-8. PubMed ID: 17460546
[TBL] [Abstract][Full Text] [Related]
18. Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli.
Dupret JM; Goodfellow GH; Janezic SA; Grant DM
J Biol Chem; 1994 Oct; 269(43):26830-5. PubMed ID: 7929420
[TBL] [Abstract][Full Text] [Related]
19. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
Martell KJ; Levy GN; Weber WW
Mol Pharmacol; 1992 Aug; 42(2):265-72. PubMed ID: 1513324
[TBL] [Abstract][Full Text] [Related]
20. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.
Ferguson RJ; Doll MA; Rustan TD; Baumstark BR; Hein DW
Pharmacogenetics; 1994 Apr; 4(2):82-90. PubMed ID: 8081415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
